公开(公告)号：US09879022B2

公开(公告)日：2018-01-30

申请号：US15232892

申请日：2016-08-10

Applicant: Pfizer Inc.

Inventor： John David Trzupek ,  Katherine Lin Lee ,  Mark Edward Bunnage ,  Seungil Han ,  David Hepworth ,  Frank Eldridge Lovering ,  John Paul Mathias ,  Nikolaos Papaioannou ,  Betsy Susan Pierce ,  Joseph Walter Strohbach ,  Stephen Wayne Wright ,  Christoph Wolfgang Zapf ,  Lori Krim Gavrin ,  Arthur Lee ,  David Randolph Anderson ,  Kevin Joseph Curran ,  Christoph Martin Dehnhardt ,  Eddine Saiah ,  Joel Adam Goldberg ,  Xiaolun Wang ,  Horng-Chih Huang ,  Richard Vargas ,  Michael Dennis Lowe ,  Akshay Patny

IPC: C07D491/056 ,  C07D401/12 ,  C07D403/12 ,  C07D405/12 ,  C07D407/14 ,  A61K31/47 ,  A61K31/517 ,  A61K31/4015 ,  A61K31/4709 ,  A61K31/4725 ,  A61K31/5377 ,  A61K31/541 ,  A61K45/06 ,  C07D207/26 ,  C07D215/48 ,  C07D413/12 ,  C07D417/12 ,  C07D487/04 ,  C07D401/14 ,  C07D405/14 ,  C07D217/02 ,  C07D217/22 ,  C07D217/24 ,  C07C69/94 ,  C07D239/86 ,  C07D239/88 ,  C07D263/24 ,  C07D207/273 ,  C07D498/04 ,  C07D209/52 ,  C07F7/18 ,  A61K31/40 ,  C07D207/08 ,  C07D207/267

CPC classification number: C07D491/056 ,  A61K31/40 ,  A61K31/4015 ,  A61K31/47 ,  A61K31/4709 ,  A61K31/4725 ,  A61K31/517 ,  A61K31/5377 ,  A61K31/541 ,  A61K45/06 ,  C07C69/94 ,  C07D207/08 ,  C07D207/26 ,  C07D207/267 ,  C07D207/273 ,  C07D209/52 ,  C07D215/48 ,  C07D217/02 ,  C07D217/22 ,  C07D217/24 ,  C07D239/86 ,  C07D239/88 ,  C07D263/24 ,  C07D401/12 ,  C07D401/14 ,  C07D403/12 ,  C07D405/12 ,  C07D405/14 ,  C07D407/14 ,  C07D413/12 ,  C07D417/12 ,  C07D487/04 ,  C07D498/04 ,  C07F7/1804

Abstract: Compounds, tautomers and pharmaceutically acceptable salts of the compounds are disclosed, wherein the compounds have the structure of Formula Ia, as defined in the specification. Corresponding pharmaceutical compositions, methods of treatment, methods of synthesis, and intermediates are also disclosed.

公开(公告)号：US20150148326A1

公开(公告)日：2015-05-28

申请号：US14608826

申请日：2015-01-29

Applicant: Pfizer Inc.

Inventor： Matthew F. Brown ,  Mark J. Mitton-Fry ,  Seungil Han ,  Manjinder Lall ,  Mark Plummer ,  Hud Lawrence Risley ,  Veerabahu Shanmugasundaram ,  Jeremy Starr

IPC: C07D417/14

CPC classification number: C07D417/14 ,  C07D205/08

Abstract: The present invention is directed to a new class of monobactam derivatives and their use for treating bacterial infections.

Abstract translation: 本发明涉及一类新颖的单链内酰胺衍生物及其用于治疗细菌感染的用途。

公开(公告)号：US20130252935A1

公开(公告)日：2013-09-26

申请号：US13778670

申请日：2013-02-27

Applicant: PFIZER INC.

Inventor： Matthew F. Brown ,  Mark J. Mitton-Fry ,  Seungil Han ,  Manjinder Lall ,  Mark Plummer ,  Hud Lawrence Risley ,  Veerabahu Shanmugasundaram ,  Jeremy Starr

IPC: C07D205/08

CPC classification number: C07D417/14 ,  C07D205/08

Abstract: The present invention is directed to a new class of monobactam derivatives and their use for treating bacterial infections.